REGENERON PHARMACEUTICALS, INC. Pre-tax Income 2008-2026 | REGN
Beta
What is REGENERON PHARMACEUTICALS, INC.'s current pre-tax income?
REGENERON PHARMACEUTICALS, INC. (REGN) annual pre-tax income for 2025 was $5.23B, a 9.43% increase from 2024. REGENERON PHARMACEUTICALS, INC. pre-tax income for the quarter ending March 31, 2026 was $831.2M.
What was REGENERON PHARMACEUTICALS, INC.'s pre-tax income in 2024?
REGENERON PHARMACEUTICALS, INC. annual pre-tax income for 2024 was $4.78B, a 13.83% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s pre-tax income in 2023?
REGENERON PHARMACEUTICALS, INC. annual pre-tax income for 2023 was $4.20B, a 13.57% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year pre-tax income CAGR?
REGENERON PHARMACEUTICALS, INC. pre-tax income grew at a compound annual growth rate (CAGR) of 6.54% from FY2020 to FY2025, going from $3.81B to $5.23B over 5 years.
Pre-tax Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+6.5%
FY2020
$3.81B
→
FY2025
$5.23B
080910111213141516171819202122232425
5 years selected
Pre-tax Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $5.23B | +9.4% | 10-K |
| FY2024 | $4.78B | +13.8% | 10-K |
| FY2023 | $4.20B | -13.6% | 10-K |
| FY2022 | $4.86B | -47.9% | 10-K |
| FY2021 | $9.33B | +144.7% | 10-K |
| FY2020 | $3.81B | +56.9% | 10-K |
| FY2019 | $2.43B | -4.9% | 10-K |
| FY2018 | $2.55B | +22.9% | 10-K |
| FY2017 | $2.08B | +56.3% | 10-K |
| FY2016 | $1.33B | +8.5% | 10-K |
| FY2015 | $1.23B | +60.9% | 10-K |
| FY2014 | $761.2M | +9.3% | 10-K |
| FY2013 | $696.4M | +68.0% | 10-K |
| FY2012 | $414.4M | +285.9% | 10-K |
| FY2011 | $-222.9M | -113.4% | 10-K |
| FY2010 | $-104.5M | -45.2% | 10-K |
| FY2009 | $-72.0M | +6.3% | 10-K |
| FY2008 | $-76.8M | - | 10-K |
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →